OTTAWA, May 9, 2017 /CNW/ - Cannabis Canada Association and its members welcome the May 5, 2017 announcement by Health Canada of new mandatory testing of medical cannabis for unauthorized pesticides, which reflects the Association's own direction, announced March 9, 2017, requiring new product testing protocols for all Association members.
"It is essential that Canadians have full confidence in the quality of their medical cannabis," said Colette Rivet, Executive Director of Cannabis Canada. "Canada has established the most rigorously regulated medical cannabis system in the world. With Health Canada governance and industry commitments, we will continue to add precision to regulatory requirements, further strengthening patient and consumer protection."
Cannabis Canada and its members work in collaboration with Health Canada and other experts to protect the health of Canadians and ensure a safe and well-regulated cannabis system in Canada. In keeping with this commitment, on March 9, 2017, Cannabis Canada announced the development of a new set of guidelines that would see Licensed Producer members of the Association provide, as a requirement of membership in 2017-2018, confirmation that their product testing protocols include bacteria, microbial, aflatoxins, heavy metals and pesticides. At the May 1, 2017 meeting of the Board of Directors, the testing requirements were specified to include both myclobutanil and bifenazate.
About Cannabis Canada Association
Cannabis Canada is the leading organization of Canada's Licensed Producers of Medical Cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).
The Association's mission is to act as the national voice for our members in their promotion of industry standards; support the development, growth and integrity of the regulated cannabis industry; and serve as an important resource on issues related to the safe and responsible use of cannabis for medical and non-medical purposes.
Members of Cannabis Canada share a philosophy of both patient-centric care and improved public health, and are committed to product safety and quality, secure and reliable access and the promotion of the safe and healthful use of cannabis. Website: www.cann-can.ca
SOURCE Cannabis Canada Association
For further information: Colette Rivet, Executive Director, Cannabis Canada Association, email@example.com, 613-407-1080